In a different cell type, BT20 breast cancer cells, knockdown of Rab4a, Rab4b, Rab11a, Rab11b or Rab25 significantly decreased motility, as did knockdown of CLINT1 or SH3BP5L. This evidence concerns the gene RAB25 and breast carcinoma.